Like HealthMode

announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/12/2018 via Forbes

Medopad, acquired Sherbit

synopsis: Medopad, a British health technology company that uses apps and wearables to monitor patient vital signs, has bought Sherbit, a rival startup in the US. Sherbit allows care teams to monitor patients through multiple apps and devices and effectively engage them with coaching, action plans, and preventative alerts.
buyer: Medopad
Medopad provides enterprise mobile health solutions. Its product includes mobile health operating system, a patient data access platform that delivers patient information and clinical applications to doctors. The company offers mobile device management solutions. "
target: Sherbit
Sherbit is a healthcare analytics company. Sherbit allows care teams to monitor patients through multiple apps and devices and effectively engage them with coaching, action plans, and preventative alerts.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/6/2021 via GlobeNewswire

Life Clips, Inc., acquired Cognitive Apps

synopsis: Life Clips, Inc. has acquired Cognitive Apps Software Solutions Inc., a Canadian developer of AI-powered applications for the healthcare industry and psychedelic research. Life Clips will further develop Cognitive Apps' technology for use in the development and testing of psychedelics for the treatment of various mental health disorders.
buyer: Life Clips, Inc. (OTCPK:LCLP:$0.00)
Life Clips is a software development company. Through the company's subsidiary, Mobeego, it develops and distributes an affordable adapter and single-use, cordless battery that provides an instant shot of power to cellular phones, so users can stay mobile whenever and wherever. "
target: Cognitive Apps
Cognitive Apps is a Canadian developer of AI-powered applications for the healthcare industry and psychedelic research. Its mental health analytics platform empowers companies to measure, understand, and improve the mental well-being of their employees, patients, or customers with easy-to-use tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2021 via BNC Analysis

Meddo, acquired Doxper

synopsis: Meddo, a digital outpatient care platform in India, has acquired Doxper, a health record management and patient engagement platform in India. Doxper is an AI powered digital pen and paper solution that allows doctors to digitise their case sheets. Their platform provides easy access to patient info and sends automated reminders to patients.
buyer: Meddo
Meddo is a digital outpatient care platform in India. Meddo is re-defining how primary and secondary healthcare is provided in India through a connected care delivery platform. Their platform allows patients to easily book appointments and consult with doctors online. "
target: Doxper
Doxper is a health record management and patient engagement platform in India. Doxper is an AI powered digital pen and paper solution that allows doctors to digitise their case sheets. Their platform provides easy access to patient info and sends automated reminders to patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/19/2021 via BNC Analysis

BCB Medical Ltd., acquired Health Solutions AB

synopsis: BCB Medical, the Finnish market leader in advanced software systems for gathering and analyzing clinical data, has acquired its Swedish partner and pioneer in health data, Health Solutions AB. Health Solutions is a pioneer in developing decision support systems to monitor patient outcomes with a focus on infectious diseases.
buyer: BCB Medical Ltd.
BCB Medical, founded in 2003 in Finland, develops disease-specific monitoring solutions with CE conformity for monitoring and analyzing clinical data in over 100 disease groups. "
target: Health Solutions AB
Health Solutions AB is a Swedish partner and pioneer in health data. Health Solutions has been a pioneer in developing decision support systems to monitor patient outcomes with a focus on infectious diseases in the Nordic region and the UK.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2020 via BNC Analysis

Milliman, Inc., acquired Healthio Inc.

synopsis: Brookfield-based and artificial intelligence startup HealthIO, which develops a platform for wearable, internet-connected devices to monitor a person’s health in between clinic visits, has been acquired by Milliman, a Seattle consulting firm.
buyer: Milliman, Inc.
Milliman is among the world's largest providers of actuarial and related products and services. They provide consulting practices in employee benefits, healthcare, investment, life insurance and financial services, and property and casualty insurance. "
target: Healthio Inc.
healthio combines the forces of IoT, Big Data and AI in healthcare to predict adverse events and progression of chronic conditions. healthio is about the DATA​: establishing a longitudinal data pattern and combining it with historical data enables intelligence for early detection.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2019 via PR Newswire

Waystar, acquired Digitize.AI, Inc.

synopsis: Waystar, a leading provider of revenue cycle technology, has acquired Digitize.AI, an artificial intelligence technology (AI) firm providing the healthcare industry with smarter prior authorizations. Digitize.AI offers AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
buyer: Waystar
Waystar provides next-generation, cloud-based technology that simplifies and unifies the healthcare revenue cycle. The Waystar platform removes friction in payment processes, streamlines workflows and improves financials for providers in every care setting. "
target: Digitize.AI, Inc.
Digitize.AI is an artificial intelligence (AI) technology firm providing the healthcare industry with faster and smarter prior authorizations. Digitize.AI offers Lia and Mia, AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

CIOX Health, acquired Medal, Inc.

synopsis: Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language Processing (biomed-NLP) technology company, Medal, Inc., a leader in the application of AI techniques to the interrogation of unstructured medical record data.
buyer parent: New Mountain Capital, LLC
buyer: CIOX Health
Ciox Health facilitates and manages the movement of health information with the industry’s broadest provider network. They improve the management and exchange of health information by modernizing workflows, facilitating access to clinical data, & improving the accuracy & flow of health information. "
target: Medal, Inc.
Medal, Inc. a leader in the application of AI techniques to the interrogation of unstructured medical record data. Medal’s software helps identify, contextualize, and interpret narrative-based medical notes, leading to the creation of research-grade data sets at scale.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/15/2020 via PR Newswire

Eversana, acquired HVH Precision Analytics

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent: Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2019 via BNC Analysis

Abeo, Inc., acquired Trusted i10

synopsis: abeo, a leader in physician-focused billing and practice management solutions, has acquired Trusted i10. Trusted i10 has proven next generation technology that solves the issue of medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
buyer parent: Parthenon Capital Partners
buyer: Abeo, Inc.
abeo Management Corporation (abeo) serves as a leading source of revenue cycle management and practice management for hospital-based specialties, originating from deep-rooted experience within Anesthesiology. "
target: Trusted i10
Trusted i10 has proven next generation technology that solves the issue created by modern electronic medical systems: medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via PE Hub

EMV Capital Ltd, acquired Wanda Health

synopsis: EMV Capital, a London-based early-stage venture investor, has acquired Wanda Inc from NetScientific, a transatlantic healthcare IP commercialisation group. Wanda is a digital health company that offers advanced clinical decision support software powered by machine learning to improve and simplify life for people with serious health risks.
buyer: EMV Capital Ltd
EMV Capital (EMVC) is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities, transportation and healthcare sectors. EMVC’s investments cover a range of technologies, including AI, machine learning, IoT, and more. "
target parent: NetScientific
target: Wanda Health
Wanda is a digital health company. Wanda offers advanced clinical decision support software powered by machine learning and real time patient data analysis to improve and simplify life for people with serious health risks. Wanda empowers clinically guided interventions to prevent rehospitalizations.
price ($mm)
$0.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2020 via BusinessWire

GI Partners, acquired Clinical Ink

synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer: GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent: NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/15/2018 via Company Press Release

NovaQuest, acquired Clinical Ink

synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer: NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2019 via BNC Analysis

Optum, acquired Vivify Health Inc.

synopsis: UnitedHealth subsidiary Optum acquired Texas-based remote patient monitoring (RPM) startup Vivify Health. Vivify equips payers and providers with a comprehensive RPM platform, complete with a suite of connected medical devices and mobile health apps.
buyer parent: UnitedHealth Group
buyer: Optum
Optum is a health services and innovation company on a mission to help make the health system work better for everyone. They combine data and analytics with technology and expertise to power modern health care. "
target: Vivify Health Inc.
Vivify equips payers and providers with a comprehensive RPM (Remote Patient Monitoring) platform, complete with a suite of connected medical devices and mobile health apps. Its platform has contributed to 76% fewer patient readmissions at University of Pittsburgh Medical Center (UPMC).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2018 via GlobeNewswire

FollowMyHealth, acquired HealthGrid

synopsis: Health IT vendor Allscripts has acquired HealthGrid through FollowMyHealth, a web based patient portal. HealthGrid gives health systems and providers a powerful enterprise patient engagement platform to connect patients anytime, anywhere, on any device.
buyer parent: Allscripts
buyer: FollowMyHealth
FollowMyHealth is a web based patient portal which allows patients to view and manage their healthcare information and connect with their providers from anywhere. FollowMyHealth is an innovator and leader in the movement toward patients taking a proactive role in managing their health and wellness. "
target: HealthGrid
HealthGrid is shifting the patient experience paradigm and meeting patients where they are. By simplifying care throughout the continuum, HealthGrid gives health systems and providers a powerful enterprise patient engagement platform to connect patients anytime, anywhere, on any device.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/13/2018 via BusinessWire

Fitbit Inc., will acquire Twine Health

synopsis: Fitbit, Inc., the leading global wearables brand, announced that it will acquire Twine Health, an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
buyer: Fitbit Inc. (FIT:$1,550.22)
Fitbit helps people lead healthier, more active lives by empowering them with data, inspiration and guidance to reach their goals. As the leader in the Connected Health & Fitness category, Fitbit designs products and experiences that track everyday health and fitness. "
target: Twine Health
Twine Health is an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2016 via PR Newswire

CRF Health, acquired Entra Health

synopsis: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, has acquired Entra Health, a global leader in mobile health IT, cloud-based remote monitoring, health data exchange and analytics solutions. The acquisition expands CRF Health's offerings into the expanding market of wireless medical and wellness devices.
buyer parent: Vitruvian Partners LLP
buyer: CRF Health
CRF Health is a leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention. "
target: Entra Health
Entra Health is a mobile health IT company focused on cloud-based remote patient monitoring, telehealth, health data exchange and analytics solutions. They provide technology solutions and services ranging from their own FDA Class II software platform to their one-stop shopping for health devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2020 via BNC Analysis

TekTone Sound & Signal, acquired Stay Smart Care

synopsis: TekTone has acquired majority ownership in Stay Smart Care, a company whose expertise lies in Remote Patient Monitoring (RPM) solutions. Stay Smart Care offers its solutions for senior living communities, at-home care models, home care agencies and Medicaid/Medicare providers.
buyer: TekTone Sound & Signal
For over 45 years, TekTone® has designed and manufactured UL® Listed Tek-CARE® nurse call, wireless nurse/emergency call, wander management, Tek-SAFE® area of rescue assistance systems, and Tek-ALERT® integration systems. "
target: Stay Smart Care
Stay Smart Care is the only senior care solution that provides continuous, non-intrusive healthcare monitoring with smart technology. Stay Smart Care offers Remote Patient Monitoring solutions for senior living communities, at-home care models, home care agencies and Medicaid/Medicare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2019 via BNC Analysis

Activa Capital, acquired Medisys SAS

synopsis: Activa Capital, a leading French mid-market private equity firm, has acquired a majority stake in Medisys, a French software publisher that specializes in the home-care field. Medisys offers management, care, mobility, and remote management software that covers various home healthcare needs.
buyer: Activa Capital
Activa Capital is a leading French mid-market private equity firm. Activa Capital manages over €500m of private equity funds on behalf of a wide range of institutional investors. Activa Capital partners with ambitious mid-sized French companies, valued at €20m to €200m. "
target: Medisys SAS
Medisys is a French software publisher that specializes in the home-care field. Medisys offers management, care, mobility, and remote management software that covers various home healthcare needs. Their solutions allow users to monitor their patients in real time, manage health records, and more.
price ($mm)
$56
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2005 via BNC Analysis

Clinical Data, Inc., will acquire Genaissance Pharmaceuticals, Inc.

synopsis: Clinical Data Inc. announced Tuesday that it will acquire Genaissance Pharmaceuticals in an all-stock transaction valued at $56 million. Genaissance shareholders will own 40 percent of the combined company when the deal closes sometime in the fourth quarter.
buyer: Clinical Data, Inc. (CLDA:$0.00)
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market. "
target: Genaissance Pharmaceuticals, Inc.
Genaissance is a world leader in the discovery and use of human gene variation for the development of a new generation of DNA-based diagnostic and therapeutic products. Genaissance markets its technology, clinical development skills and Pharmacogenomic support services to the pharmaceutical industr
price ($mm)
$56
rev ($mm)
$21
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
closed 10/26/2010 via Market Wire

Unity Management Group, Inc, acquired Metropolitan Computer Corporation

synopsis: Unity Management Group, Inc announced that it has successfully completed the acquisition of Metropolitan Computer Corporation (MCC/ Legacy).
buyer: Unity Management Group, Inc (US:UYMG:$0.00)
Unity Management Group is a health resource company, which provides quality physician practice management services, that offer high value, and significant return, through its three subsidiary companies. United Healthcare Solutions, Unity Technologies Inc., and United Business Services. "
target: Metropolitan Computer Corporation
Metropolitan Computer Corporation (MCC/ Legacy) designs, engineers, markets, and services instrumentation equipment and software systems for increased efficiency within the pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/6/2012 via PR Newswire

CareFusion Corporation, will acquire PhACTs, LLC.

synopsis: CareFusion Corporation announced an agreement to acquire PHACTS, LLC, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.
buyer: CareFusion Corporation (CFN:$3,598.00)
CareFusion Corporation is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. "
target: PhACTs, LLC.
PHACTS was formed to serve Health Systems with multiple hospitals and/or clinics, doctors' offices, surgery centers and other locations, which need to account for and provide medications and pharmacy supplies across their network.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2018 via BNC Analysis

MindMaze, acquired Neuro Motor Innovations Corporation

synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer: MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
target: Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2012 via BusinessWire

MeadWestvaco Corporation, acquired AARDEX Group SA

synopsis: MeadWestvaco Corporation announced that it is expanding its leading position in adherence packaging with the acquisition of AARDEX Group SA. AARDEX is the leader and pioneer in the design and use of electronic medication event monitoring systems and applications designed to measure, analyze, and manage patient adherence in clinical drug trials.
buyer: MeadWestvaco Corporation (WRK:$6,049.00)
MeadWestvaco Corporation provides packaging solutions to many of the world’s most-admired brands in the healthcare, beauty and personal care, food, beverage, home and garden, and tobacco industries. "
target: AARDEX Group SA
AARDEX Group is the pioneer and world leader in developing, manufacturing, and marketing MEMS™, Medication Event Monitoring System, which measures, analyzes and facilitates patients' adherence to prescribed drug dosing regimens in clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2004 via BusinessWire

Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,

synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
target: Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x

Like HealthMode


read more

HealthMode

Sherbit

Cognitive Apps

Doxper

Health Solutions AB

Healthio Inc.

Digitize.AI, Inc.

Medal, Inc.

HVH Precision Analytics

Trusted i10

Wanda Health

Viewics, Inc.

Clinical Ink

Clinical Ink

Vivify Health Inc.

HealthGrid

Twine Health

Entra Health

Stay Smart Care

Medisys SAS

read more

HealthMode

read more

HealthMode

read more

AAIPharma Services

Genaissance Pharmaceuticals, Inc.

Metropolitan Computer Corporation

PhACTs, LLC.

Livongo

BreathResearch

Neuro Motor Innovations Corporation

Telcare

AARDEX Group SA

Apogent Technologies, Inc.

Geography
Matching Companies
Ticker: CNSX:PHGI
 
 
 
 
 
 
 
 
Premier Health Group Inc.
Premier Health is strategically poised to take advantage of business opportunities in the global health care industry. Their subsidiary, HealthVue, is focused on developing proprietary technology to deliver quality healthcare through the combination of telemedicine and artificial intelligence (AI).
year
2020
rev ($mm)
$9.28
EBITDA ($mm)
($6.35)
EBIT ($mm)
($6.38)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:HNSS
 
 
 
 
 
 
 
 
Healthnostics, Inc.
Healthnostics, Inc.
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information.
year
2012
rev ($mm)
$0.20
EBITDA ($mm)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:PKS
 
 
 
 
 
 
 
 
Pacific Knowledge Systems
Pacific Knowledge Systems
Pacific Knowledge Systems (PKS) is an Australian provider of clinical expert intelligence. Their RippleDown solution integrates patient data with a knowledge base that is managed by clinical domain experts, to deliver patient-specific reports, recommendation and alerts.
year
2021
rev ($mm)
$6.12
EBITDA ($mm)
($0.30)
EBIT ($mm)
($0.35)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCQB: EHVVF
 
 
 
 
 
 
 
 
Ehave, Inc.
Ehave, Inc.
Ehave is a healthcare company developing a next generation of digital solutions for stakeholders in the medical cannabis and mental health sectors. Ehave’s health informatics platform efficiently captures high-quality, objective user data.
year
2020
rev ($mm)
EBITDA ($mm)
($2.05)
EBIT ($mm)
($2.85)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: TSXV:CRBK
 
 
 
 
 
 
 
 
Carebook Technologies Inc.
Carebook Technologies Inc.
Built on a powerful health platform, Carebook creates highly engaging, customer-centric digital products for pharmacies, insurance providers, governments, businesses, and more. Carebook’s core is science and technology, and its goal is accessible, connected health for everyone.
year
2020
rev ($mm)
$2.87
EBITDA ($mm)
($4.24)
EBIT ($mm)
($4.44)
Net Income ($mm)
Employees
38
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MRK
 
 
 
 
 
 
 
 
Merck & Co., Inc.
Merck & Co., Inc.
Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they deliver health solutions.
year
2020
rev ($mm)
$48,081.00
EBITDA ($mm)
$19,058.00
EBIT ($mm)
$15,735.00
Net Income ($mm)
$10,147.00
Employees
71000
  • drill down
  • watch
Ticker: OTCPK:MMED.F
 
 
 
 
 
 
 
 
MindMed
MindMed
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances.
year
2020
rev ($mm)
EBITDA ($mm)
($24.86)
EBIT ($mm)
($25.61)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:AVX
 
 
 
 
 
 
 
 
Avexa Limited
Avexa is a biotechnology company dedicated to the discovery and development of new drugs to treat serious infectious diseases, particularly Human Immunodeficiency Virus (HIV). They are based in Australia.
year
2015
rev ($mm)
$0.24
EBITDA ($mm)
($1.45)
EBIT ($mm)
($1.46)
Net Income ($mm)
Employees
5
  • drill down
  • watch
Ticker: COV
 
 
 
 
 
 
 
 
Covidien
Covidien
Tyco Healthcare became Covidien and began independently trading on the New York and Bermuda Stock Exchanges on July 2, 2007, marking its debut as an independent diversified global healthcare products company.
year
2010
rev ($mm)
$10,429.00
EBITDA ($mm)
$2,628.00
EBIT ($mm)
$2,139.00
Net Income ($mm)
$1,632.00
Employees
41500
  • drill down
  • watch
Ticker: JNJ
 
 
 
 
 
 
 
 
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company operates through three business segments, including Consumer; Pharmaceutical and Medical Devices; and Diagnostics.
year
2019
rev ($mm)
$81,325.00
EBITDA ($mm)
$27,998.00
EBIT ($mm)
$21,066.00
Net Income ($mm)
$16,332.00
Employees
135100
  • drill down
  • watch
Ticker: CAH
 
 
 
 
 
 
 
 
Cardinal Health, Inc.
Cardinal Health, Inc.
Cardinal Health, Inc. improves the cost-effectiveness of the health care industry. Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability.
year
2018
rev ($mm)
$141,935.00
EBITDA ($mm)
$2,870.00
EBIT ($mm)
$1,860.00
Net Income ($mm)
Employees
50200
  • drill down
  • watch
Ticker: BDX
 
 
 
 
 
 
 
 
Becton, Dickinson and Company
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a leading medical technology company. BD’s innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research.
year
2020
rev ($mm)
$17,117.00
EBITDA ($mm)
$4,569.00
EBIT ($mm)
$2,415.00
Net Income ($mm)
$874.00
Employees
65000
  • drill down
  • watch
Ticker: FMS
 
 
 
 
 
 
 
 
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
As a vertically integrated company, we offer products and services for the entire dialysis value chain. The highest medical standards are our benchmark.
year
2009
rev ($mm)
$11,247.48
EBITDA ($mm)
$2,212.68
EBIT ($mm)
$1,755.60
Net Income ($mm)
$891.14
Employees
72812
  • drill down
  • watch
Ticker: FAGR
 
 
 
 
 
 
 
 
Fagron
Fagron
Fagron is an innovative scientific pharmaceutical R&D company that is focused on optimising and innovating pharmaceutical compounding worldwide. Fagron offers Fagron Compounding Essentials, Fagron Trademarks and Fagron Compounding Services to pharmacies and hospital pharmacies in 30 countries.
year
2014
rev ($mm)
$473.30
EBITDA ($mm)
$113.50
EBIT ($mm)
$96.32
Net Income ($mm)
$17.17
Employees
1902
  • drill down
  • watch
Ticker: RMD
 
 
 
 
 
 
 
 
ResMed
ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
year
2019
rev ($mm)
$2,784.41
EBITDA ($mm)
$858.38
EBIT ($mm)
$696.96
Net Income ($mm)
$454.92
Employees
7240
  • drill down
  • watch
Ticker: NMRD
 
 
 
 
 
 
 
 
Nemaura Medical, Inc.
Nemaura Medical, Inc.
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT.
year
2020
rev ($mm)
EBITDA ($mm)
($4.72)
EBIT ($mm)
($4.78)
Net Income ($mm)
Employees
17
  • drill down
  • watch
Ticker: ABT
 
 
 
 
 
 
 
 
Abbott Laboratories
Abbott Laboratories
Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
year
2021
rev ($mm)
$37,338.00
EBITDA ($mm)
$10,357.00
EBIT ($mm)
$6,924.00
Net Income ($mm)
$5,724.00
Employees
109000
  • drill down
  • watch
Ticker: SYK
 
 
 
 
 
 
 
 
Stryker Corporation
Stryker Corporation
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties.
year
2016
rev ($mm)
$10,062.00
EBITDA ($mm)
$2,717.00
EBIT ($mm)
$2,312.00
Net Income ($mm)
$1,617.00
Employees
27000
  • drill down
  • watch
Ticker: HOLX
 
 
 
 
 
 
 
 
Hologic, Inc.
Hologic, Inc.
Hologic is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications.
year
2011
rev ($mm)
$1,789.35
EBITDA ($mm)
$595.38
EBIT ($mm)
$290.64
Net Income ($mm)
$157.15
Employees
5019
  • drill down
  • watch
Ticker: ASX:SFP
 
 
 
 
 
 
 
 
Safety Medical Products Ltd
Safety Medical Products Limited has various patents and registered trademarks associated with the SecureTouch syringe in regions and countries including Europe, the United States of America, Africa, Australia and New Zealand.
year
2013
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.77)
Net Income ($mm)
Employees
  • drill down
  • watch